Skip to main content

Table 1 Drug susceptibility profiles of PAS-resistant MDR-TB and PAS-susceptible isolates

From: Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations

Drug resistance profile (n = 102)

Number of strains

Proportion (%)

PAS-resistant isolates (n = 20)

 INH + RIF + SM + EMB + LVX + AMK + CPM + KM + OFX

9

8.8

 INH + RIF + SM + EMB + LVX + AMK + CPM + OFX

1

1.0

 INH + RIF + SM + EMB + LVX + CPM + KM + OFX

1

1.0

 INH + RIF + SM + EMB + LVX + CPM + OFX

3

2.9

 INH + RIF + SM + EMB + LVX + AMK + KM + OFX

4

3.9

 INH + RIF + SM + EMB + LVX + AMK + OFX

2

2.0

PAS-susceptible isolates (n = 82)

 INH + SM + CPM

1

1.0

 SM + AMK + CPM

1

1.0

 INH + SM

5

5.0

 SM + CPM

4

4.0

 SM + EMB

5

5.0

 INH

2

2.0

 SM

36

35.3

 EMB

1

1.0

 LVX

16

15.7

 CPM

1

1.0

Susceptible to all drugs

10

9.8

  1. INH isoniazid, RIF rifampin, SM streptomycin, EMB ethambutol, LVX levofloxacin, AMK amikacin, CPM capreomycin, KM kanamycin, OFX ofloxacin